Pfizer Hit With $73M Verdict In Menopause Drug Suit

Law360, New York (December 6, 2011, 10:58 PM EST) -- A Pennsylvania jury reportedly ordered Pfizer Inc. on Tuesday to pay $72.6 million in damages to three women who say they developed breast cancer after taking menopause drugs made by the company's Wyeth and Pharmacia & Upjohn subsidiaries.

The jury in the Philadelphia Court of Common Pleas awarded $20 million in compensatory damages to Susan Elfont, while Bernadette Kalenkoski received $27.85 million and Judy Mulderig received $24.75 million, according to Bloomberg News.

A spokesman for Pfizer said in a statement Tuesday that the final determination of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.